PFAS and cancer, a scoping review of the epidemiologic evidence

Background: The number of studies addressing per-and polyfluoroalkyl substances (PFAS) and cancer is increasing. Many communities have had water contaminated by PFAS, and cancer is one of the important community concerns related to PFAS exposure. Objectives: We critically reviewed the evidence relating to PFAS and cancer from an epidemiologic standpoint to highlight directions for future research that would be the most likely to meaningfully increase knowledge. Methods: We conducted a search in PubMed for studies of cancer and PFAS (through 9/20/2020). We identified epidemiologic studies that provided a quantitative estimate for some measure of the association between PFAS and cancer. Here, we review that literature, including several aspects of epidemiologic study design that impact the usefulness of study results. Results: We identified 16 cohort (or case-cohort) studies, 10 case-control studies (4 nested within cohorts and 6 non-nested), 1 cross sectional study and 1 ecologic study. The cancer sites with the most evidence of an asso-ciation with PFAS are testicular and kidney cancer. There are also some suggestions in a few studies of an as-sociation with prostate cancer, but the data are inconsistent. Discussion: Each study's design has strengths and limitations. Weaknesses in study design and methods can, in some cases, lead to questionable associations, but in other cases can make it more difficult to detect true asso-ciations, if they are present. Overall, the evidence for an association between cancer and PFAS remains sparse. A variety of studies with different strengths and weaknesses can be helpful to clarify associations between PFAS and cancer. Long term follow-up of large-sized cohorts with large exposure contrasts are most likely to be informative.

Automated summary

This study critically reviewed the evidence relating to PFAS and cancer, finding a strong association with testicular and kidney cancer. However, there are inconsistencies in the data regarding prostate cancer. Long-term follow-up of large cohorts with high exposure contrasts is likely to provide more informative results.